Pharmaceutical News

RSS
China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

New spinout company to tackle drug-resistant infections with novel antibiotics

New spinout company to tackle drug-resistant infections with novel antibiotics

Greater awareness of science can help public overcome fear of vaccines

Greater awareness of science can help public overcome fear of vaccines

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

As states try to rein in drug spending, feds slap down one bold Medicaid move

As states try to rein in drug spending, feds slap down one bold Medicaid move

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

New research hub to drive radical change in development and manufacturing of vaccines

New research hub to drive radical change in development and manufacturing of vaccines

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

UAB researchers study dysfunction of the immune system associated with NSAID carprofen

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Vax-Hub to influenze radical change in development and manufacturing of vaccines

ALSAM Foundation invests additional $2 million for drug discovery and development projects

ALSAM Foundation invests additional $2 million for drug discovery and development projects

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance

Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

Study: Infants using popular anti-reflux medicines are not at increased risk of lung infections

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

UTILITY receives FDA approval for Investigational New Drug applications

UTILITY receives FDA approval for Investigational New Drug applications